Neonatology pp 577-584 | Cite as

Arrhythmias and Heart Muscle Diseases

  • Fabio Mosca
  • Federico Schena
  • Anna Maria Colli


Physiological cardiac electrical activity is characterized by sinus rhythm consisting of a regular sequence of activation of the atria (shown on the surface electrocardiograph [ECG] as a P wave), the atrioventricular (AV) node (PR interval), the ventricular myocardium (the QRS complex) and return to electrical rest (the T wave). The heart-beats show a regular cadence and the morphology of the EKG does not vary.


Ventricular Tachycardia Kawasaki Disease Right Ventricle Hypertrophic Cardiomyopathy Atrial Flutter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Moak JP, Hamra M (2000) Cardiac electrophysiology. In: Garson A Jr, Bricker JT, Fisher DJ, Neish SR (eds) The Science and Practice of Pediatric Cardiology, 2nd edn. Lippincott Willams & Wilkins, Baltimore, London, pp 369–411Google Scholar
  2. 2.
    Vignati G (1999) Manuale di aritmologia pediatrica. McGraw-Hill Libri, MilanoGoogle Scholar
  3. 3.
    Perry JC (2000) Supraventricular tachycardia. In: Garson A Jr, Bricker JT, Fisher DJ, Neish SR (eds) The science and practice of pediatric cardiology, 2 edn. Lippincott Willams & Wilkins, Baltimore, London, pp 2059–2101Google Scholar
  4. 4.
    Ludomirsky A, Garson A Jr (1990) Supraventricular syndromes. In: Gillette PC, Garson A Jr (ed) Pediatric arrhythmias, electrophysiology and pacin. WB Saunders, Philadelphia, pp 380–426Google Scholar
  5. 5.
    Moak J (2000) Supraventricular tachycardia in the neonate and infant. Prog Pediatr Cardiol 11: 25–38PubMedCrossRefGoogle Scholar
  6. 6.
    Wong KK, Potts JE, Etheridge SP, Sanatami S (2006) Medications used to manage supraventricular tachycardia in the infant: a north American survey. Pediatr Cardiol 27:199–203PubMedCrossRefGoogle Scholar
  7. 7.
    Rosenthal E (2006) Pitfalls in the use of adenosine. Arch Dis Child 91: 451Google Scholar
  8. 8.
    Weinding SN, Saul JP, Walsh EP (1996) Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 13: 66–72CrossRefGoogle Scholar
  9. 9.
    Dubin A (2000) Antiarrhythmic therapy in the neonate. Prog Pediatr Cardiol 11: 55–63PubMedCrossRefGoogle Scholar
  10. 10.
    Till JA, Shinebourne EA, Rowland E et al (1989) Pediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics. Br Heart J 62: 133–139PubMedCrossRefGoogle Scholar
  11. 11.
    Fenrich AL, Perry JC, Friedman RA (1995) Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy. J Am Coll Cardiol 25: 1195–1198PubMedCrossRefGoogle Scholar
  12. 12.
    Drago F, Silvetti MS, Bevilacqua M et al (2001) Permanent junctional reciprocating tachycardia in infants and children: effectiveness of medical and non medical treatment. Ital eart J 2: 456–461Google Scholar
  13. 13.
    O’Sullivan JJ, Gardiner HM, Wren C (1995) Digoxin or flecainide for prophylaxis of supraventricular tachicardia in infants? J Am Coll Cardiol 26: 991–994PubMedCrossRefGoogle Scholar
  14. 14.
    Dixon J, Foster K, Wyllie J, Wren C (2005) Guidelines and adenosine dosing in supraventricular tachycardia. Arch Dis Child 90: 1190–1191PubMedCrossRefGoogle Scholar
  15. 15.
    Dick M II, Scott WA, Serwer GS et al (1988) Acute termination ofsupraventricular tachyarrhythmias in children by trans-esophageal pacing. Am J Cardiol 61:925–927PubMedCrossRefGoogle Scholar
  16. 16.
    Lipshultz SE, Sleeper LA, Towbin JA et al (2003) The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348:1647–1655PubMedCrossRefGoogle Scholar
  17. 17.
    Nugent AW, Daubeney PE, Chondros P et al (2003) The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 1639–1646Google Scholar
  18. 18.
    Badertscher A, Bauersfeld U, Arbenz U et al (2008) Cardiomyopathy in newborns and infants: a broad spectrum of aetiologies and poor prognosis. Acta Paediatr 97:1523–1528PubMedCrossRefGoogle Scholar
  19. 19.
    Nugent AW, Daubeney PE, Chondros P et al (2005) Clinical features and outcomes of childhood hypertrophic cardiomyopathy. Circulation 112:1332–1338PubMedCrossRefGoogle Scholar
  20. 20.
    Towbin JA, Lowe AM, Colan SD et al (2006) Incidence, causes and outcomes of dilated cardiomyopathy in children. JAMA 296: 1867– 1876PubMedCrossRefGoogle Scholar
  21. 21.
    Cox GF, Sleeper LA, Lowe AM et al (2006) Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics 118:1519–1531PubMedCrossRefGoogle Scholar
  22. 22.
    Cox GF (2007) Diagnostic Approaches to Pediatric Cardiomyopathy of Metabolic Genetic Etiologies and Their Relation to Therapy. Prog Pediatr Cardiol 24: 15–25PubMedCrossRefGoogle Scholar
  23. 23.
    Harmon WG, Sleeper LA, Cuniberti L et al (2009) Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol 104: 281–286PubMedCrossRefGoogle Scholar
  24. 24.
    Ostman-Smith I, Wettrell G, Riesenfeld T (1999) A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol 34: 1813–1822PubMedCrossRefGoogle Scholar
  25. 25.
    Ichida F, Hamamichi Y, Miyawaki T et al (1999) Clinical features of isolated noncompaction of the ventricular myocardium: longterm clinical course, hemodynamic properties, and genetic background. J Am Coll Cardiol 34: 233–240PubMedCrossRefGoogle Scholar
  26. 26.
    Pignatelli RH, McMahon CJ, Dreyer WJ et al (2003) Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 108: 2672–2678PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Fabio Mosca
    • 1
  • Federico Schena
  • Anna Maria Colli
  1. 1.Neonatal Intensive Care Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore PoliclinicoUniversity of MilanMilanItaly

Personalised recommendations